Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 6, 2008, Pages 445-450

  Hill, E E ^a   Peetermans, W E ^a   Vanderschueren, S ^a   Claus, P ^a   Herregods, M C ^a   Herijgers, P ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; CARDIOGENIC SHOCK; CATHETER INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBOLISM; FEMALE; HEART FAILURE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; MORTALITY; PERSISTENT INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; TREATMENT CONTRAINDICATION;

ANTI-BACTERIAL AGENTS; CATHETERS, INDWELLING; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENDOCARDITIS; ENDOCARDITIS, BACTERIAL; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 44249098069     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0458-2     Document Type: Article

References (21)

1. Mylonakis E, Calderwood SB (2001) Medical progress: Infective endocarditis in adults. N Engl J Med 345:1318-1330
2. Mouly S, Ruimy R, Launay O, Arnoult F, Brochet E, Trouillet JL, Leport C, Wolff M (2002) The changing clinical aspects of infective endocarditis: Descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 45:246-256
3. Loupa C, Mavroidi N, Boutsikakis I, Paniara O, Deligarou O, Manoli H, Saroglou G (2004) Infective endocarditis in Greece: a changing profile. Epidemiological, microbiological and therapeutic data. Clin Microbiol Infect 10:556-561
4. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012-3021
5. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE (2007) Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 28(2):196-203
6. Cabell CH, Abrutyn E, Fowler VG Jr, Hoen B, Miro JM, Corey GR, Olaison L, Pappas P, Anstrom KJ, Stafford JA, Eykyn S, Habib G, Mestres CA, Wang A (2005) Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J 150:1092-1098
7. Yoon HJ, Choi JY, Kim CO, Kim JM, Song YG (2005) A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis. Yonsei Med J 46:496-502
8. Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL (2003) A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82:322-332
9. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633-638
10. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT (1995) Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 274:1706-1713
11. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:3167-3184
12. Moon MR, Stinson EB, Miller DC (1997) Surgical treatment of endocarditis. Prog Cardiovasc Dis 40:239-264
13. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, Soler-Soler J, Thiene G, von Graevenitz A, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernandez Burgos E, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Lekakis J, Vahanian A, Delahaye F, Parkhomenko A, Filipatos G, Aldershvile J, Vardas P (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis - Executive summary. Eur Heart J 25:267-276
14. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE (2001) Guidelines for the management of intravascular catheter related infections. Clin Infect Dis 32:1249-1272
15. Chen SC, Dwyer DE, Sorrell TC (1992) A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol 70:1449-1452
16. Terpenning MS, Buggy BP, Kauffman CA (1988) Hospital-acquired infective endocarditis. Arch Intern Med 148:1601-1603
17. Hsu RB (2005) Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26:654-657
18. Levine DP, Fromm BS, Reddy BR (1991) Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 115:674-680
19. Valtonen V, Kuikka A, Syrjanen J (1993) Thrombo-embolic complications in bacteraemic infections. Eur Heart J 14(Suppl K):20-23
20. Syrjanen J (1993) Infection as a risk factor for cerebral infarction. Eur Heart J 14(Suppl K):17-19
21. Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger-Bachi B (1998) Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob Agents Chemother 42:564-570